ImmunityBio(US:IBRX) Benzinga·2026-02-11 18:01Group 1 - Financial giants have shown a bullish sentiment towards ImmunityBio, with 57% of traders being bullish and 26% bearish in recent options trades [1] - The analysis revealed a total of 19 unusual trades, with 17 calls valued at $1,230,478 and 2 puts valued at $71,500 [1] - Major market movers are focusing on a price range between $3.5 and $7.5 for ImmunityBio over the last three months [2] Group 2 - The assessment of volume and open interest indicates significant liquidity and investor interest in ImmunityBio's options within the strike price range of $3.5 to $7.5 over the past 30 days [3] - Analysts have issued ratings for ImmunityBio, with a consensus target price of $14.8, indicating positive market sentiment [5] - Currently, ImmunityBio's stock is trading at $6.5 with a volume of 10,382,277, reflecting a decrease of -0.99% [6]